Trader consensus on Polymarket reflects a 93% implied probability for no new coronavirus pandemic in 2026, driven by CDC and WHO surveillance data showing COVID-19 circulating at low endemic levels, with test positivity at 1.8% as of early April and infections declining in 38 U.S. states per recent Rt estimates. Despite the emergence of highly mutated variants like BA.3.2 ("Cicada"), detected in wastewater across 31 states, transmission remains contained without surges in hospitalizations or deaths warranting WHO's Public Health Emergency of International Concern designation. Global risk assessments classify ongoing SARS-CoV-2 activity as moderate, bolstered by updated 2025-2026 vaccines targeting dominant strains. Realistic challenges include a novel variant with extreme immune escape and rapid global spread, though model consensus and historical patterns post-Omicron favor sustained management; watch forthcoming WHO vaccine deliberations and weekly epidemiological updates.